Modern aspects of managing patients with inflammatory diseases of the external and middle ear

Introduction. The article considers approaches to the management of patients with inflammatory diseases of the middle ear at the outpatient and hospital stages.
Aim. To substantiate the guidelines for endaural treatment of inflammatory ear diseases with Anauran® ear drops from the perspective of the best clinical efficiency.
Materials and methods. A total of 53 patients (106 ears) were examined, of which 21 patients were diagnosed with otitis externa diffusa (24 ears), 23 patients (25 ears) with acute catarrhal otitis media and 9 patients (9 ears) with epitympanitis in remission, who underwent type 1 tympanoplasty. The efficacy of Anauran® as part of combination treatment was compared in the following age groups: in patients over 18 years old (mean age 39.2 ± 11.1 years) and in children (mean age 9.8 ± 6.5 years).
Results and discussion. Absolute scores determined in assessing ear pain in the group of patients with acute otitis externa diffusa ranged from 3 to 9 scores; in the group with acute catarrhal otitis media – from 3 to 8 scores, in patients after tympanoplasty – from 2 to 8 scores. There was some difference in the assessment of the ear pain severity between children and patients over 18 years of age. The most short-term changes in ear pain occurred in children with acute otitis externa diffusa and acute catarrhal otitis media. As a result, the vast majority of patients showed a clinical effect on Day 7, which consisted in the recovery of the otoscopic status, a decrease in complaints by up to 96.3% in adults and up to 96.1% in children. The use of Anauran® ear drops in the complex management of patients with inflammatory diseases of the middle ear reduces the duration of treatment and eliminates problems with secondary bacterial infections in the postoperative period.
Conclusions. The findings support the high efficiency of Anauran® in the combination therapeutic treatment of inflammatory processes of the outer and middle ear.

1. Nikitin K.A., Arustamyan I.G., Bolozneva E.V. Local etiotropic treatment for acute external and otitis media. Meditsinskiy Sovet. 2013;(7):22–25. (In Russ.) https://doi.org/10.21518/2079-701X-2013-7-22-25.

2. Nikiforova G.N., Svistushkin V.M., Dedova M.G. Possibilities of local therapy of infectious and inflammatory diseases of the upper respiratory tract. RMJ. 2015;(6):346. (In Russ.) Available at: https://www.rmj.ru/archive/otorinolaringologiya_8/.

3. Turovsky A.B., Kryukov A.I. Acute inflammation of the outer and middle ear. Consilium Medicum. 2000;8(2):323–325. (In Russ.) Available at: https://consilium.orscience.ru/2075-1753/article/view/91296.

4. Kosyakov S.Ya. Inflammatory diseases of the external auditory canal and methods of their treatment. Vestnik Oto-Rino-Laringologii. 2011;(1):81–85. (In Russ.) Available at: https://www.mediasphera.ru/issues/vestnikotorinolaringologii/2011/1/.

5. Morozova S.V., Karapetyan L.S. An integrated approach to the treatment of patients with otitis externa. Farmateka.2017;6(339):7–11. (In Russ.) Available at: https://pharmateca.ru/ru/archive/article/34740.

6. Kunelskaya V.Ya. New approaches to the treatment of fungal otitis media. Vestnik Oto-Rino-Laringologii. 2004;(2):46–48. (In Russ.) Available at: https://www.mediasphera.ru/issues/vestnik-otorinolaringologii/2004/2/.

7. Kustov M.O., Artyushkin S.A., Nacharov P.V., Verzhbitskiy G.V., Artyushkina V.K., Grebenshchikova L.A. Microflora of the external auditory canal in patients with bacterial external diffuse otitis media. Rossiiskaya Otorinolaringologiya. 2012;3:66–70. (In Russ.) Available at: https://cyberleninka.ru/article/n/mikroflora-naruzhnogo-sluhovogo-prohoda-u-bolnyh-bakterialnymnaruzhnym-diffuznym-otitom.

8. Kunelskaya V.Ya., Shadrin G.B., Rasskazova T.V., Kalinina I.B. Otitis media. The role of bacterial and fungal infection. Meditsinskiy Sovet. 2013;(7):11–17. (In Russ.) https://doi.org/10.21518/2079-701X-2013-7-11-17.

9. Kryukov A.I., Shadrin G.B., Gurov A.V., Ivoylov A.Yu., Karneeva O.V., Magomedov M.M. Otitis externa. Clinical guidelines. Moscow, 2021. (In Russ.) Available at: https://otolar-centre.ru/images/2022/Clinical/%D0%9D%D0%B0%D1%80%D1%83%D0%B6%D0%BD%D1%8B%D0%B5_%D0%BE%D1%82%D0%B8%D1%82%D1%8B.pdf.

10. Palchun V.T. (eds.) Otorhinolaryngology: national guidelines. Moscow: GEOTAR-Media; 2008. 960 p. (In Russ.)

11. Svistushkin V.M., Ovchinnikov A.Yu., Nikiforova G.N. Local therapy for inflammatory diseases of the outer and middle ear. Modern view of the problem. Rossiiskaya Otorinolaringologiya. 2005;(3):93–96. (In Russ.) Available at: https://medi.ru/info/2762.

12. Nosulya E.V., Kunelskaya V.Ya., Kim I.A., Luchsheva Yu.V. External otitis: clinical diagnostics and treatment tactics. Vestnik Oto-Rino-Laringologii. 2021;86(3):36–40. (In Russ.) https://doi.org/10.17116/otorino20218603136.

13. Okovity S.V., Ivkin D.Yu., Malygin S.V. Drug therapy of otitis externa and otitis media. Vestnik Oto-Rino-Laringologii. 2012;1:19–25. (In Russ.) Available at: https://www.mediasphera.ru/issues/vestnik-otorinolaringologii/2012/1/downloads/ru/030042-46682012116.

14. Nikiforova G.N., Svistushkin V.M. Rational topical etiotropic treatment of inflammatory diseases of the outer and middle ear. Effective Pharmacotherapy. 2013;(10):8–14. (In Russ.) Available at: https://umedp.ru/articles/ratsionalnoe_topicheskoe_etiotropnoe_lechenie_vospalitelnykh_zabolevaniy_naruzhnogo_i_srednego_ukha.html.

15. Shevchik E.A., Nikiforova G.N., Svistushkin V.M. Some aspects of the treatment of inflammatory diseases of the external ear. RMJ. 2014;(9):655. (In Russ.) Available at: https://www.rmj.ru/articles/obshchie-stati/Nekotorye_aspekty_terapii_vospalitelynyh_zabolevaniy_narughnogo_uha/.

16. Ovchinnikov A.Yu., Miroshnichenko N.A., Smirnov I.V. Modern approach to the treatment of otitis externa and otitis media. Farmateka. 2018;3(356):71–74. (In Russ.) https://doi.org/10.18565/pharmateca.2018.3.71-74.